RANK as a therapeutic target in cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RANK as a therapeutic target in cancer

Published:2016-01-28 Issue:11 Volume:283 Page:2018-2033
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

González-Suárez Eva¹,Sanz-Moreno Adrián¹

Affiliation:

1. Cancer Epigenetics and Biology Program; Bellvitge Biomedical Research Institute, IDIBELL; Barcelona Spain

Funder

Ministerio de Economía y Competitividad

FEDER funds/European Regional Development Fund (ERDF)

Fundació la Marató de TV3

Susan Komen Foundation Career Catalyst Research grant

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/febs.13645/fullpdf

Reference133 articles.

1. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function;Anderson;Nature,1997

2. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density;Simonet;Cell,1997

3. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation;Lacey;Cell,1998

4. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL;Yasuda;Proc Natl Acad Sci USA,1998

5. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells;Wong;J Biol Chem,1997

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological progression of osteoarthritis: a perspective on subchondral bone;Frontiers of Medicine;2024-04

2. Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy;Cellular and Molecular Life Sciences;2024-02-29

3. Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk;Cell Stem Cell;2024-01

4. The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive;International Journal of Molecular Sciences;2023-10-23

5. Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells;Acta Pharmaceutica;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3